10 Most Promising Stocks to Buy Before They Take Off
In this article, we discuss the 10 most promising stocks to buy before they take off.
Biogen Inc. (BIIB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 10,034 | $2,164 | -60% | 0.5% |
| 2. | Impax Asset Management Ian Simm | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $222.54 | 455 | Director | 20,629 | 2024-02-15 | Filing | |
| $267.00 | 898 | Director | 2,943 | 2021-02-09 | Filing | |
| $241.31 | 3,100 | Officer, Director | 34,810 | 2020-11-30 | Filing | |
| $231.24 | 38,000 | Director | 643,000 | 2019-05-02 | Filing | |
| $229.46 | 30,000 | Director | 605,000 | 2019-05-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $213.09 | 93 | Officer | 4,886 | 2024-04-02 | Filing | |
| $221.23 | 262 | Officer | 4,886 | 2024-02-22 | Filing | |
| $221.49 | 108 | Officer | 5,148 | 2024-02-16 | Filing | |
| $239.45 | 419 | Officer | 4,516 | 2024-02-12 | Filing | |
| $245.93 | 634 | Officer | 4,097 | 2024-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,264,481 | $4,208,759,748 | 3.33% | |
| 2. | 14,407,330 | $3,728,184,783 | 0.08% | |
| 3. | 14,246,658 | $3,686,607,689 | 0.09% | |
| 4. | 6,945,665 | $1,797,329,732 | 0.08% | |
| 5. | 5,324,396 | $1,377,793,953 | 0.25% |
News See All
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45.
Should You Be Confident in Biogen (BIIB)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here.
5 Best Depressed Stocks To Buy in 2024
Biogen Inc (NASDAQ:BIIB) shares are down 27% over the past one year.
5 Best S&P 500 Stocks To Buy According to Analysts
In this piece, we will take a look at the five best S&P 500 stocks to buy according to analysts.
Hedge Funds and Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at Hedge Funds and Insiders Are Buying These 10 Stocks. For a quick overview of such stocks, read our article Hedge Funds and Insiders Are Buying These...
20 Highest Paying Countries for Biotechnology
In this article, we will look at the 20 highest-paying countries for biotechnology. We have also discussed the global biotechnology market along with key trends and players.
5 Best Beaten Down Stocks To Buy Right Now
In this piece, we will take a look at the five best beaten down stocks to buy right now.
20 Most Sustainable Companies in the US
According to the SDSN Sustainable Development Report 2023, the United States demonstrates mixed performance on sustainable development goals, especially with respect to infrastructure, innovation, and...
Biogen Inc. (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript
Biogen Inc. beats earnings expectations. Reported EPS is $3.3, expectations were $3.16. Biogen Inc.
Billionaire Hedge Funds
